Short answer
As of November 2026, US telemedicine providers need LegitScript certification before Google or Meta will run their prescription-drug advertising, and online pharmacies need it for Meta and LegitScript or NABP for Google. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats certification as a launch dependency, because campaigns planned around an uncertified account will not deliver. Google names LegitScript as the accreditation for US telemedicine providers, and Meta requires active LegitScript certification plus its own authorization to promote a prescription drug.
What is LegitScript certification for?
LegitScript is a third party that certifies healthcare merchants and advertisers, and the major ad platforms rely on that certification as a precondition for running certain healthcare categories. MedScale works with telehealth brands and clinics, and the practical consequence is consistent across them: certification is not a document filed after launch, it is the gate that determines whether launch is possible at all.
LegitScript certification exists because platforms cannot evaluate the legitimacy of every healthcare advertiser themselves. Outsourcing that judgment lets them permit a regulated category while limiting exposure to bad actors.
Which telehealth businesses fall within LegitScript's scope?
LegitScript's scope is broader than most founders expect. It is not limited to businesses that describe themselves as online pharmacies.
- Telemedicine providers offering virtual consultations that can result in a prescription.
- Online pharmacies and businesses that dispense or arrange dispensing of prescription medication.
- Brands whose funnel routes a patient to a prescriber, even where the brand itself never handles medication.
Brands that never touch medication are the group that surprises people. A marketing-facing brand that positions itself as a wellness company can still sit within scope if the funnel ends at a prescription, because platforms assess what the funnel does rather than how the brand describes itself. MedScale maps what a client's funnel does before planning any prescription campaign for that reason.
The platforms draw the line in different places. Google's healthcare policy allows US telemedicine providers accredited by LegitScript's Healthcare Merchant Certification Program and online pharmacies accredited by LegitScript or NABP, and requires Google's own certification on top. Meta requires telehealth providers to be actively certified with LegitScript and authorized by Meta before promoting a prescription drug, but needs no written authorization for ads that promote telehealth services generally. Update, November 9, 2026: Google announced on November 4, 2026 that telemedicine providers accredited through the Healthcare Merchant Accreditation Program of the National Association of Boards of Pharmacy (NABP) will be eligible to apply for Google Ads telemedicine certification once its November 2026 policy update is published, as an additional option alongside LegitScript, and that advertisers must be NABP-accredited before applying to Google. Meta still requires telehealth providers to be actively certified with LegitScript.
What does the LegitScript certification process involve?
Certification is an evidence exercise. Applicants are asked to document their corporate structure, their licensed clinicians and the states or territories they are licensed in, their pharmacy relationships, and the way patient data is handled. LegitScript's pricing page, checked October 5, 2026, lists $975 to apply per website, nonrefundable, and $2,150 a year per website once approved, with $2,500 more to have review start within two business days. The LegitScript cost calculator at /tools/legitscript-cost-calculator turns those fees into a first-year budget.
The realistic planning assumption is that certification takes long enough to matter to a launch calendar. Brands that treat it as a formality to complete during the media plan routinely lose a quarter waiting. MedScale's LegitScript support covers preparing that evidence and the filing, so the application starts before the campaign build does. For a brand that hasn't launched yet, MedScale's telehealth launch starts the LegitScript readiness review alongside the launch plan, so the filing is moving before any campaign is built.
Does LegitScript certification make your ads compliant?
Treating certification as creative clearance is the most expensive misunderstanding in the category. Certification establishes that the advertiser is permitted to run in a restricted vertical. It says nothing about whether any particular ad complies with the platform's content policies.
A certified telehealth advertiser can still have ads disapproved for prohibited claims, imagery, or targeting, and can still accumulate the kind of disapproval pattern that puts an account at risk. MedScale keeps the two workstreams separate for that reason: certification clears the category, and creative structure clears the review.
How do you keep LegitScript certification active?
LegitScript certification is not permanent. It is tied to the business as documented at the time of application, so material changes to the clinical model, the states served, the pharmacy relationships, or the corporate entity can require an update. Letting certification lapse produces exactly the same symptom as never having had it: account-wide disapprovals that no amount of creative work will fix. MedScale treats a lapsed certificate like a missing one, so the fix goes to the certificate, not the creative.
Common questions
- 01Do I need LegitScript certification if I only sell supplements?
- Generally not, if nothing in the funnel involves prescription medication or a prescriber relationship. The distinction matters less than brands assume, though: platforms assess what the funnel actually does, so a supplement brand that routes patients toward a prescription can fall into scope.
- 02Does LegitScript certification cover every advertising platform?
- No. Several major platforms recognize it, but each keeps its own policies and its own certification process on top. LegitScript's own FAQ says certification may be required for certain advertising programs but does not guarantee advertising approval, so each platform should be confirmed separately rather than assumed to follow Google's lead.
- 03How long does LegitScript certification take?
- There is no fixed time: LegitScript publishes no standard review time. Expedited processing, at $2,500 per application, starts the review within two business days of submission but does not promise a decision date. The wait is long enough to break a launch calendar, so it belongs at the start of the plan rather than alongside campaign build.
- 04Can my agency apply for certification on my behalf?
- Not in the agency's name. Certification attaches to the healthcare business, so the application has to come from the operating entity with its own clinical and corporate documentation. An agency such as MedScale can prepare and manage the submission, but the certificate stays with the business.
Sources
- 01LegitScript: Healthcare Certification process and pricingchecked October 5, 2026
- 02LegitScript: Healthcare Certification FAQchecked October 5, 2026
- 03Google Ads policy: Healthcare and medicineschecked October 5, 2026
- 04Google Ads policy: Prescription drug serviceschecked October 5, 2026
- 05Meta Advertising Standards: Drugs and Pharmaceuticalschecked October 5, 2026
- 06Google Ads policy: Update to Healthcare and Medicines Policy (November 2026), posted Nov 4, 2026 (NABP option for telemedicine)checked November 9, 2026
- 07Meta Business Help Center: About Meta's Prescription Drugs advertising policy (rechecked Nov 9, 2026)checked November 9, 2026
Related answers
How Much Does LegitScript Certification Cost in 2026?
As of October 2026, LegitScript Healthcare Certification costs $975 per website to apply, nonrefundable, plus $2,150 per website each year once approved, so a single-domain telehealth brand pays $3,125 in year one. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats that fee as the cheapest line in a prescription-drug ad budget, because Google and Meta will not run those ads without it. Expedited review adds $2,500 per application, and the $2,150 renews every year.
Reviewed October 24, 2026
Why Are Your Google Ads Disapproved for Telehealth, and How Do You Fix It?
As of October 2026, Google disapproves telehealth ads for three recurring reasons: the advertiser is not certified to promote telemedicine or prescription medication, the landing page makes claims the policy treats as unsupported, or the campaign promotes a substance Google restricts outright. MedScale Health, a paid ads agency for US telehealth brands and clinics, checks certification status first, because an uncertified account keeps failing review however carefully the creative is written.
Reviewed October 24, 2026
Can You Advertise GLP-1 on Google Ads?
As of October 2026, a GLP-1 telehealth brand can advertise on Google Ads once it holds LegitScript accreditation and Google's certification, which Google requires before prescription drug service ads serve in the United States. MedScale Health, a paid ads agency for US telehealth brands and clinics, sequences certification, then landing pages, then keywords. An in-person clinic may name semaglutide or tirzepatide in US ad text and landing pages without certification since October 29, 2025, but needs certification to keyword-target those terms.
Reviewed October 24, 2026
How Do Meta, Google and TikTok Differ on Telehealth Advertising?
As of October 2026, Google gates telehealth ads at the advertiser (LegitScript and Google certification), Meta at the content (plus LegitScript and authorization for prescription drug ads), and TikTok at the product (US prescription ads need proof of FDA approval). MedScale Health, a paid ads agency for US telehealth brands and clinics, plans the channel mix around those three gates and runs TikTok only for non-prescription offers. Compounded drugs cannot meet TikTok's rule, and its prescription ads must target people 18 or older.
Reviewed October 24, 2026
Last reviewed November 9, 2026. Platform policies change often; we re-verify every answer quarterly.